We've Seen This Before... and It Didn't End Well

Strange events are unfolding in the global financial system. A monetary reset dubbed the "Mar-a-Lago Accord" is quietly in motion, and the financial elite are already taking protective action. If history is any guide, you could lose up to 40% of your wealth in the next two years. Move your money before it's too late.

Helen Mirren opens Stella McCartney’s activist, cruelty-free Paris runway

THOMAS ADAMSON
September 30, 2025

PARIS (AP) -- Inside the Centre Pompidou, Helen Mirren opened Stella McCartney 's Paris Fashion Week show with a spoken rendition of The Beatles ' "Come Together." Less performance than manifesto, it set the tone for a Tuesday night collection framed around humanity, animals and Mother Earth.

McCartney has long been ahead of the curve in fashion's sustainability push. This season she claimed her most conscious offering yet: 98% sustainable, 100% cruelty-free. No leather, no fur, no feathers, no exotic skins. Instead came world-first innovations: FEVVERS, a plant-based alternative to feathers, and PURE.TECH, a programmable fabric that absorbs pollutants from the air.

If the message was serious, the mood was not. A pounding bass line and rave-like lights kept energy high as Robin Wright, Dylan Penn and Johnny Depp watched from the front row.

McCartney's silhouettes explored opposites -- masculine and feminine, grounded and ethereal. Savile Row tailoring was deconstructed: double-breasted jackets sliced open at the sides, draped with dropped lapels, worn over pleated wide trousers and '80s Italian-inspired shirting. Cargo codes reappeared in crisp minis fringed with airy crinoline.

Colors shifted from candy pinks, lavenders and blues into khaki, corporate gray and pecan. Upcycling was visible. Denim waistbands collaged into dresses, bags and even platform shoes. Sequins glimmered across Falabella clutches and hand-embroidered denim. Evening pared back to sculptural satin gowns and corseted draping animated by the new feather substitute.

The collection captured McCartney's recurring aesthetic -- eco-lux innovation, '80s-inflected power dressing, activist theater softened by British wit.

At times the campaigning risks overwhelming the clothes, her shows veering into didactic spectacle.

Still, Tuesday night confirmed why McCartney remains unique after two decades -- she can merge spectacle and conscience, sustainability and desirability, daring her audience to imagine fashion that doesn't just dress the body, but tries to heal the planet.

Continue Reading...

Popular

FBI Director Kash Patel Bought 2 Stocks In 2025 — One's Already A Meme Favorite

FBI Director Kash Patel was asked about two stocks he bought earlier this year by a member of Congress on Wednesday and gave a surprising answer. The transactions come as members of Congress are working on legislation to ban lawmakers and cabinet members from buying and selling stocks.

Senate Democrats Reject Funding Bill, Increasing Chances Of Government Shutdown By Oct. 1

Senate Democrats have rejected a stopgap spending bill passed earlier Friday by the House. This result has put Washington on the brink of a potential government shutdown, which could take place on Oct. 1.

Digital Gold. Digital Oil. Digital Infrastructure. - Ad

Bitcoin and Ethereum had their turn. Now a NASDAQ-listed firm is scaling BNB, which fuels 290M users and pays yield.

TikTok Stays Online As Trump Extends US Deadline, Washington Still Demands ByteDance Divestment

President Trump said he and Chinese President Xi Jinping made progress on a TikTok deal and will meet in South Korea in just over a month.

Pilgrims turn Spain's Santiago de Compostela into the world's latest overtourism flashpoint

SANTIAGO DE COMPOSTELA, Spain (AP) — While some Barcelona residents sought to repel a tsunami of tourists , a neighborhood association in Santiago de Compostela opted for a friendlier approach: a guide to good manners for visitors to their town, the endpoint of the Catholic world's most famous pilgrimage.

Rare Disease Biotech Offers Access Ahead of Key Milestone - Ad

This late-stage biotech is gearing up for Phase 2 trials with an FDA-designated orphan drug. It's already drawing comparisons to recent billion-dollar exits. Backed by a proven biotech incubator, it's now offering early access to its raise.

Kroger Posts Q2 Beat, Analyst Says Restructuring 'Shows Signs Of Success'

Kroger raised its 2025 ID sales, ex-fuel, guidance to 2.7%-3.4%, from its earlier forecast of 2.25%-3.25%.

Biotech With Multiple Orphan Drugs Is Quietly Opening Its Doors - Ad

A promising biotech developing treatments for rare childhood brain diseases is opening a new raise. Its lead drug has fast-track status, orphan designations, is nearing Phase 2 and backed by a Global Integrator.

Nio, Rivian, Moderna, Meta And Bitmine Immersion: Why These 5 Stocks Are On Investors' Radars Today

On Tuesday, U.S. markets slipped, with the Dow Jones Industrial Average falling about 0.3% to 45,757.90, the S&P 500 retreating 0.1% to 6,606.76, and the Nasdaq edging down 0.07% to 22,333.96.These are the top stocks that gained the attention of retail traders and investors throughout the day.

Charlie Kirk Raised $85 Million Last Year — Widow Vows to Continue His Work

The assassination of Turning Point USA founder Charlie Kirk at a Utah Valley University event on September 10 has cast a shadow of uncertainty over the future of his political and business ventures.

The First Public Cash-Flowing Digital Treasury - Ad

Unlike Bitcoin vaults, this NASDAQ-listed company earns yield through BNB staking and nodes. $368M already deployed, still overlooked.

Cathie Wood Loads Up On Bullish Inc, Pony AI And Robinhood — Dumps Kratos Defense Amid Taiwan Drone Buzz

On Sept 17, 2025, Cathie Wood-led Ark Invest executed significant trades involving Bullish, Kratos Defense, Pony AI, and Robinhood. These reflect Ark's focus on emerging tech and defense sectors.

US orders Delta and Aeromexico to dissolve their partnership over fairness concerns in Mexico

U.S. Transportation Secretary Sean Duffy is following through on to force Delta and Aeromexico to dissolve their longtime partnership because of his concerns that Mexico isn't being fair to U.S. airlines.

New Biotech Offering Targets $426B Rare Disease Market - Ad

The rare disease drug space is growing fast-and so is investor interest. With exclusivity, pricing power and major M&A moves, the rare disease space is getting interesting. This company has the science and the experience.

Bitcoin, Ethereum, Dogecoin Hold Steady As XRP Slips Ahead Of PPI Data

Cryptocurrency markets opened Wednesday on a cautious note, trading slightly lower ahead of the latest U.S. Producer Price Index (PPI) data release.

FDA Approval Could Send This Stock Soaring - Ad

Whenever the FDA approves a new drug... Timely investors could see 300-400% returns... ChemoCentryx soared 281% in the year after it won FDA approval... Immunogen jumped 449% in the two years after it won FDA approval... Even Krystal Biotech rose 242% when it looked like it would win FDA approval, which it did.

Johnson & Johnson's Tecvayli-Darzalex Combo Shows 100% Response In Newly Diagnosed Myeloma Patients

Johnson & Johnson's Tecvayli-Darzalex regimen showed 100% response rates and high MRD negativity in newly diagnosed multiple myeloma patients.

Gov. Whitmer to address Michigan's economy as possible state and federal shutdowns loom

LANSING, Mich. (AP) — Three years ago, the story of Michigan was one of Democratic success. and Democratic state lawmakers of the executive and legislative branches of government.

The Tesla Shock Nobody Sees Coming - Ad

While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.

What's Going On With Starbucks Stock Today?

Starbucks stock is steady as it opens a Bernabéu flagship in Madrid, while international comps were flat and Q3 International revenue rose 9% to $2B.

Here's Novo Nordisk's First Oral Obesity Drug In Europe With Proven Heart Health Impact

EMA approved Rybelsus' label update after the SOUL trial showed it cuts heart attack, stroke, and death by 14% in high-risk type 2 diabetes patients.

Elon's $25 Trillion Confession - Ad

Elon Musk: "Tesla will become a $25 trillion company." That would make Tesla 8x bigger than Apple today. How is that possible? He admits it's all thanks to this one AI breakthrough that will take AI out of our computer screens and manifest a 250x boom here in the real world.

Asian shares retreat after Intel helped drive Wall Street to more records

MANILA, Philippines (AP) — Asian shares mostly retreated Friday after a rally of technology stocks led by Nvidia and Intel

Elizabeth Warren, Jack Reed Warn SEC Against 'Significant Mistake' Of Curbing Shareholder Lawsuits Against Companies: Report

Sen. Elizabeth Warren (D-Mass) and other democrats have issued a stern warning to the Securities and Exchange Commission (SEC) against any potential policy change that could limit shareholders' ability to sue companies.

The Next Evolution in Public Treasuries - Ad

MicroStrategy proved the model with BTC. Now a NASDAQ-listed firm is running it with BNB, yield, and 290M users. $368M locked in.

Trump's plan for a drug advertising crackdown faces many hurdles

WASHINGTON (AP) — Health Secretary Robert F. Kennedy Jr. and other administration officials are vowing a crackdown on deceptive drug ads, but the effort is likely to face multiple headwinds, including pushback from industry and layoffs among regulators tasked with leading the effort.

Gov. Stein requests $13.5B more from Congress for Hurricane Helene recovery

FLAT ROCK, N.C. (AP) — North Carolina Gov. Josh Stein on Monday requested $13.5 billion more from Congress in recovery aid for almost a year after the historic storm, saying additional help is needed from Washington to address record amounts of damage and to get funds to the region quicker.

We've Seen This Before... and It Didn't End Well - Ad

Strange events are unfolding in the global financial system. A monetary reset dubbed the "Mar-a-Lago Accord" is quietly in motion, and the financial elite are already taking protective action. If history is any guide, you could lose up to 40% of your wealth in the next two years. Move your money before it's too late.

Digital Gold. Digital Oil. Digital Infrastructure. - Ad

Bitcoin and Ethereum had their turn. Now a NASDAQ-listed firm is scaling BNB, which fuels 290M users and pays yield.

FAA seeks $3.1 million in fines from Boeing over safety violations, 2024 midair panel blowout

The Federal Aviation Administration is seeking $3.1 million in fines from Boeing over safety violations, including ones related to an Alaska Airlines jetliner losing a door plug panel on its fuselage in midflight.

Rare Disease Biotech Offers Access Ahead of Key Milestone - Ad

This late-stage biotech is gearing up for Phase 2 trials with an FDA-designated orphan drug. It's already drawing comparisons to recent billion-dollar exits. Backed by a proven biotech incubator, it's now offering early access to its raise.

How 4 key infrastructure projects centered in Italy will reshape the European travel map

MILAN (AP) — Workers will begin drilling and blasting open the first tunnel connecting Austria to Italy under the Brenner Pass through the Alps on Thursday, marking a major milestone in a series of ambitious European Union projects that will accelerate passenger train travel between metropolitan centers and shift freight off the roads and onto rails.

Cathie Wood's Ark Dumps $2.1 Million Of This Hot AI Stock Despite Recent Acquisition Boost

On Tuesday, Cathie Wood-led Ark Invest sold shares of Tempus AI Inc (NASDAQ: TEM) through ARK Genomic Revolution ETF (ARKG) and ARK Innovation ETF (ARKK) totaling $2.1 million. This follows Tempus AI's recent acquisition and mixed analyst ratings. Other key trades include purchases of Prime Medicine Inc (PRME) and Twist Bioscience Corp (TWST).

Biotech With Multiple Orphan Drugs Is Quietly Opening Its Doors - Ad

A promising biotech developing treatments for rare childhood brain diseases is opening a new raise. Its lead drug has fast-track status, orphan designations, is nearing Phase 2 and backed by a Global Integrator.

What to Stream: Cardi B, a movie about Bumble, 'Morning Show' and a look at Lilith Fair

Cardi B releasing her long-awaited sophomore LP, “Am I the Drama?,” and Lily James playing the founder of the popular dating app Bumble in the new biographical drama “Swiped” are some of the new television, films, music and games near you.

Trending Now

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright markethundred.com
Privacy Policy | Terms of Service